Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fluid infusion during postpartum hemorrhage: a secondary analysis of the Obstetric Bleeding Study (OBS) Plus prospective observational study.

International journal of obstetric anesthesia·2026
Same author

Precarious but Possible: A Qualitative Study of the Landscape of Gig Work for People Living with Disabilities and Future Recommendations for Best Practices.

Journal of occupational rehabilitation·2025
Same author

HIV and diabetes impair <i>M. tuberculosis</i>-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing.

IJTLD open·2024
Same author

Azimuthal Correlations within Exclusive Dijets with Large Momentum Transfer in Photon-Lead Collisions.

Physical review letters·2023
Same author

Alcohol use among people who inject drugs living with HIV in Kenya is associated with needle sharing, more new sex partners, and lower engagement in HIV care.

AIDS and behavior·2023
Same author

Cognition and freezing of gait in Parkinson's disease: A systematic review and meta-analysis.

Neuroscience and biobehavioral reviews·2023

Related Experiment Video

Updated: Jul 13, 2026

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

Ovulation suppression for endometriosis.

E Hughes1, J Brown, J J Collins

  • 1McMaster University, Department of Obstetrics and Gynaecology, 1200 Main St West, Room HSC-4F7, Hamilton, Ontario, Canada L8N 3Z5. hughese@mcmaster.ca

The Cochrane Database of Systematic Reviews
|July 20, 2007
PubMed
Summary

Ovulation suppression agents do not improve pregnancy rates for women with endometriosis-associated subfertility. This systematic review found no evidence of benefit from treatments like danazol, progestins, or oral contraceptives for conception.

More Related Videos

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis
08:16

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis

Published on: February 26, 2019

Related Experiment Videos

Last Updated: Jul 13, 2026

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis
08:16

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis

Published on: February 26, 2019

Area of Science:

  • Reproductive Medicine
  • Gynecology
  • Infertility Research

Background:

  • Endometriosis is characterized by endometrial tissue outside the uterus and is estrogen-dependent.
  • This hormonal link has led to the use of ovulation suppression agents to enhance fertility.

Purpose of the Study:

  • To evaluate the efficacy of ovulation suppression agents in treating endometriosis-related subfertility.
  • To assess improvements in pregnancy and live birth outcomes.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) comparing ovulation suppression agents with placebo, no treatment, or other agents.
  • Searched multiple databases including Cochrane, MEDLINE, and EMBASE up to October 2007.
  • Data extraction and quality assessment by independent reviewers; meta-analysis using odds ratios.

Main Results:

  • Twenty-four RCTs were included. Ovulation suppression showed no significant benefit over placebo or no treatment for pregnancy rates (OR 0.79-0.80).
  • Compared to danazol, gonadotropin-releasing hormone agonists (GnRHAs) showed a benefit for pregnancy (OR 1.45-1.63), but GnRHAs were not superior to oral contraceptives.
  • Statistical heterogeneity was low across all analyses (I²=0%).

Conclusions:

  • Current evidence does not support the use of ovulation suppression agents for subfertile women with endometriosis seeking conception.
  • Further research may be needed to clarify the role of specific agents or patient subgroups.